The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: BROKER RATINGS SUMMARY: Buy Wolseley, Sell Berkeley - Goldman

Wed, 29th Jun 2016 14:39

LONDON (Alliance News) - The following shares received analyst recommendations Monday afternoon and morning:
----------
FTSE 100
----------
GOLDMAN RAISES WOLSELEY TO 'BUY' ('NEUTRAL') - TARGET 4,226 (4,294) PENCE
----------
GOLDMAN CUTS BERKELEY GROUP TO 'SELL' ('NEUTRAL') - TARGET 2,110 (4,000) PENCE
----------
GOLDMAN CUTS PERSIMMON PRICE TARGET TO 1,269 (2,280) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 365 (698) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TAYLOR WIMPEY PRICE TARGET TO 123 (231) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TRAVIS PERKINS PRICE TARGET TO 1,452 (2,236) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS INTU PROPERTIES PRICE TARGET TO 314 (350) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS LAND SECURITIES PRICE TARGET TO 1,200 (1,410) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HAMMERSON PRICE TARGET TO 670 (750) PENCE - 'BUY'
----------
GOLDMAN CUTS BRITISH LAND CO PRICE TARGET TO 736 (910) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ARM HOLDINGS TO 'BUY' (CONVICTION BUY) - PRICE TARGET 1275 (1400) PENCE
----------
SHORE CAPITAL RAISES PROVIDENT FINANCIAL TO 'BUY' ('HOLD')
----------
GOLDMAN CUTS WHITBREAD PRICE TARGET TO 3,910 (4,490) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES INTERCONTINENTAL HOTELS TARGET TO 3,120 (3,090)P - 'NEUTRAL'
----------
GOLDMAN CUTS EASYJET TO 'BUY' ('CONVICTION BUY') - TARGET 1,310 (1,740) PENCE
----------
GOLDMAN RESUMES SHIRE WITH 'CONVICTION BUY LIST' - TARGET 6,300 PENCE
----------
GOLDMAN RAISES ASTRAZENECA PRICE TARGET TO 4000 (3700) PENCE - 'SELL'
----------
GOLDMAN RAISES RELX TARGET TO 1360 (1320) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PEARSON PRICE TARGET TO 845 (800) PENCE - 'SELL'
----------
GOLDMAN CUTS INFORMA PRICE TARGET TO 836 (839) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS ITV PRICE TARGET TO 198 (258) PENCE - 'BUY'
----------
GOLDMAN CUTS WPP PRICE TARGET TO 1,800 (1,860) PENCE - 'BUY'
----------
GOLDMAN CUTS SKY PRICE TARGET TO 1013 (1254) PENCE - 'BUY'
----------
GOLDMAN CUTS SCHRODERS PRICE TARGET TO 2,800 (3,400) PENCE - 'BUY'
----------
GOLDMAN CUTS VODAFONE PRICE TARGET TO 260 (265) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BT GROUP PRICE TARGET TO 540 (650) PENCE - 'CONVICTION BUY LIST'
----------
FTSE 250
----------
GOLDMAN CUTS COUNTRYWIDE TO 'SELL' ('NEUTRAL') - TARGET 218 (465) PENCE
----------
GOLDMAN RAISES GREAT PORTLAND TO 'NEUTRAL' ('SELL') - TARGET 690 (850) PENCE
----------
GOLDMAN RAISES DERWENT LONDON TO 'BUY' ('NEUTRAL') - TARGET 3,100 (3,815) PENCE
----------
GOLDMAN CUTS CREST NICHOLSON TO 'NEUTRAL' ('CONVICTION BUY') CUTS PRICE TARGET TO 384 (755) PENCE
----------
GOLDMAN CUTS BELLWAY TO 'NEUTRAL' ('BUY') - TARGET 1,715 (3,590) PENCE
----------
GOLDMAN CUTS REDROW TO 'NEUTRAL' ('BUY') - TARGET 301 (595) PENCE
----------
GOLDMAN CUTS MCCARTHY & STONE PRICE TARGET TO 161 (275) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BOVIS HOMES TO 'NEUTRAL' ('BUY') - TARGET 684 (1,320) PENCE
----------
GOLDMAN RAISES SHAFTESBURY PRICE TARGET TO 1,061 (1,026) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS SEGRO PRICE TARGET TO 475 (555) PENCE - 'BUY'
----------
GOLDMAN CUTS HOWDEN JOINERY GROUP PRICE TARGET TO 376 (515) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS AA PRICE TARGET TO 340 (390) PENCE - 'BUY'
----------
GOLDMAN CUTS WILLIAM HILL PRICE TARGET TO 310 (380) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASCENCIAL TARGET TO 269 (278) PENCE - 'BUY'
----------
GOLDMAN RAISES UBM PRICE TARGET TO 750,37 (690,70) PENCE - 'BUY'
----------
GOLDMAN CUTS TULLETT PREBON PRICE TARGET TO 315 (390) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ICAP PRICE TARGET TO 460 (520) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MAN GROUP PRICE TARGET TO 155 (200) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS INTERMEDIATE CAPITAL PRICE TARGET TO 565 (685) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 310 (325) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ABERDEEN ASSET MANAG PRICE TARGET TO 270 (288) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SECURE INCOME TO 'NEUTRAL' ('BUY') - TARGET 308 (355) PENCE
----------
GOLDMAN CUTS DAILY MAIL PRICE TARGET TO 584 (628) PENCE - 'SELL'
----------
GOLDMAN CUTS FOXTONS TO 'SELL' ('NEUTRAL') - TARGET 96 (198) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.